ClinicalTrials.Veeva

Menu

Animal and Plant Proteins and Glucose Metabolism (HP)

University of Missouri (MU) logo

University of Missouri (MU)

Status

Enrolling

Conditions

Glucose Metabolism Disorders
Metabolic Syndrome, Protection Against
Metabolic Syndrome

Treatments

Other: High animal protein whole food
Other: High plant protein whole food
Other: High animal protein isolate
Other: High plant protein isolate

Study type

Interventional

Funder types

Other

Identifiers

NCT03994367
2097498

Details and patient eligibility

About

The goal of this proposal is to determine the effect of a high protein diet in which the increase in protein intake is derived from different sources (animal vs plant and protein-rich whole foods vs protein isolates) on: i) liver and muscle insulin sensitivity; ii) the metabolic response to a meal, and iii) 24-h plasma concentration profiles of glucose, glucoregulatory hormones, and protein-derived metabolites purported to cause metabolic dysfunction.

Enrollment

100 estimated patients

Sex

All

Ages

21 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age: ≥21 and ≤70 years;
  • BMI: >24.5 and <32.5 kg/m2;
  • habitual protein intake <0.9 g/kg/day (assessed on 2 weekdays and 2 weekend days by using the HealthWatch 360 app); and
  • weight stable (i.e., ≤3% change) and untrained (≤150 min of structured exercise/week) for at least 2 months before entering the study.

Exclusion criteria

  • prediabetes or type 2 diabetes;
  • evidence of chronic kidney disease by medical history or laboratory tests (glomerular filtration rate <60 ml/min/1.73 m2 or an albumin to creatinine ratio in urine ≥30 mg/g);
  • vegetarians or vegans;
  • intolerance or allergies to ingredients in the metabolic meal or intervention diet;
  • take dietary supplements (e.g., pre- and probiotics, fiber, fish oil) or medications known to affect our study outcomes;
  • received antibiotic or antifungal treatment (which affect the microbiome and therefore microbial metabolite production) 2 months before entering the study;
  • consume tobacco products or excessive alcohol (women: >14 drinks/week; men: >21 drinks/week);
  • evidence of significant organ system dysfunction or diseases (e.g., cirrhosis), and
  • unwilling or unable to provide informed consent.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 5 patient groups

Standard protein (control)
No Intervention group
High animal protein isolate
Experimental group
Treatment:
Other: High animal protein isolate
High animal protein whole food
Experimental group
Treatment:
Other: High animal protein whole food
High plant protein isolate
Experimental group
Treatment:
Other: High plant protein isolate
High plant protein whole food
Experimental group
Treatment:
Other: High plant protein whole food

Trial contacts and locations

1

Loading...

Central trial contact

BETTINA MITTENDORFER

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems